Latest News

A new episode of trial talk has been released today covering the STREAM2 trial for World TB Day.
Methodologists from the MRC Clinical Trials Unit at UCL have published two papers focusing on issues surrounding the monitoring of clinical trials.
A strategy of treating patients with a two-month, intensive antibiotic regimen, followed by close monitoring and re-treatment if required, was as effective at treating tuberculosis (TB) as the standard six-month regimen.
New findings from the TRISST study reveal that it would be cost effective to replace potentially harmful CT scans with MRI to monitor men after surgery for early stage testicular cancer.
A low-dose COVID-19 vaccine harnessing self-amplifying RNA (saRNA) can trigger an immune response in the majority without any serious side effects, according to phase II trial results from the COVAC1 study.